Constantine Alifrangis Selected Research

Constantine Alifrangis Research Topics

Disease

10	Neoplasms (Cancer) 07/2021 - 07/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 06/2012
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 08/2022 - 01/2018
3	Testicular Neoplasms (Testicular Cancer) 07/2021 - 01/2018
2	Seminoma 08/2022 - 01/2022
2	Mesothelioma 01/2018 - 01/2018
2	Melanoma (Melanoma, Malignant) 02/2015 - 01/2015
2	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2013 - 07/2012
1	Ejaculatory Dysfunction 01/2022
1	Neutropenia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Febrile Neutropenia 01/2021
1	Mediastinal Diseases 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Necrosis 01/2018
1	Malignant Mesothelioma 01/2018
1	Thymoma (Thymic Carcinoma) 02/2015
1	Infections 01/2012
1	Breast Neoplasms (Breast Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2017
2	SteroidsIBA 01/2021 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2013
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2020
2	AndrogensIBA 01/2020 - 06/2012
2	PlatinumIBA 01/2019 - 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AntiemeticsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021
1	Estrogens (Estrogen)FDA Link 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 01/2019
1	LigandsIBA 01/2018
1	Death Domain ReceptorsIBA 01/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	ABT-737IBA 02/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2015
1	MK 2206IBA 02/2015
1	PLX 4720IBA 02/2015
1	trametinibIBA 01/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Vincristine (Oncovin)FDA LinkGeneric 01/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 08/2022 - 07/2012
8	Therapeutics 08/2022 - 06/2012
2	Radiotherapy 08/2022 - 01/2022
2	Castration 01/2020 - 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 01/2022
1	Length of Stay 01/2022
1	Orchiectomy (Orchidectomy) 01/2021
1	Immunotherapy 01/2019
1	Thoracotomy 07/2012